Leading science, pioneering therapies

CRM Publications

Found 22 results
Filters: Keyword is Cell Line, Tumor  [Clear All Filters]
2015
Yang C-T, Méjard R, Griesser HJ, Bagnaninchi PO, Thierry B.  2015.  Cellular micromotion monitored by long-range surface plasmon resonance with optical fluctuation analysis.Anal Chem. 87(3):1456-61.
Severi F, Conticello SG.  2015.  Flow-cytometric visualization of C>U mRNA editing reveals the dynamics of the process in live cells.RNA Biol. 12(4):389-97.
2014
Sarvi S, Mackinnon AC, Avlonitis N, Bradley M, Rintoul RC, Rassl DM, Wang W, Forbes SJ, Gregory CD, Sethi T.  2014.  CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist.Cancer Res. 74(5):1554-65.
2013
Stricker SH, Feber A, Engström PG, Carén H, Kurian KM, Takashima Y, Watts C, Way M, Dirks P, Bertone P et al..  2013.  Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner.Genes Dev. 27(6):654-69.
2012
Danovi D, Folarin AA, Baranowski B, Pollard SM.  2012.  High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines.Methods Enzymol. 506:311-29.
Balikova A, Jääger K, Viil J, Maimets T, Kadaja-Saarepuu L.  2012.  Leukocyte marker CD43 promotes cell growth in co-operation with β-catenin in non-hematopoietic cancer cells.Int J Oncol. 41(1):299-309.
2011
Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, König J, Hortobágyi T, Nishimura AL, Zupunski V et al..  2011.  Characterizing the RNA targets and position-dependent splicing regulation by TDP-43.Nat Neurosci. 14(4):452-8.
Schrader J, Gordon-Walker TT, Aucott RL, Van Deemter M, Quaas A, Walsh S, Benten D, Forbes SJ, Wells RG, Iredale JP.  2011.  Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells.Hepatology. 53(4):1192-205.
2010
Herrero-González S, Gangoso E, Giaume C, Naus CC, Medina JM, Tabernero A.  2010.  Connexin43 inhibits the oncogenic activity of c-Src in C6 glioma cells.Oncogene. 29(42):5712-23.
Lagger S, Meunier D, Mikula M, Brunmeir R, Schlederer M, Artaker M, Pusch O, Egger G, Hagelkruys A, Mikulits W et al..  2010.  Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans.EMBO J. 29(23):3992-4007.
Paíno T, Gangoso E, Medina JM, Tabernero A.  2010.  Inhibition of ATP-sensitive potassium channels increases HSV-tk/GCV bystander effect in U373 human glioma cells by enhancing gap junctional intercellular communication.Neuropharmacology. 59(6):480-91.
Alexander LM, Pernagallo S, Livigni A, Sanchez-Martin RM, Brickman JM, Bradley M.  2010.  Investigation of microsphere-mediated cellular delivery by chemical, microscopic and gene expression analysis.Mol Biosyst. 6(2):399-409.
Gravel S, Malouf C, Boulais PE, Berchiche YA, Oishi S, Fujii N, Leduc R, Sinnett D, Heveker N.  2010.  The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.J Biol Chem. 285(49):37939-43.
2009
Slomiany MG, Dai L, Bomar PA, Knackstedt TJ, D Kranc A, Tolliver L, Maria BL, Toole BP.  2009.  Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.Cancer Res. 69(12):4992-8.
Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M et al..  2009.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.Cell Stem Cell. 4(6):568-80.
Sanchez-Martin RM, Alexander LM, Muzerelle M, Cardenas-Maestre JM, Tsakiridis A, Brickman JM, Bradley M.  2009.  Microsphere-mediated protein delivery into cells.Chembiochem. 10(9):1453-6.
Leimgruber E, Seguín-Estévez Q, Dunand-Sauthier I, Rybtsova N, Schmid CD, Ambrosini G, Bucher P, Reith W.  2009.  Nucleosome eviction from MHC class II promoters controls positioning of the transcription start site.Nucleic Acids Res. 37(8):2514-28.
2008
Kadaja-Saarepuu L, Laos S, Jääger K, Viil J, Balikova A, Lõoke M, Hansson GC, Maimets T.  2008.  CD43 promotes cell growth and helps to evade FAS-mediated apoptosis in non-hematopoietic cancer cells lacking the tumor suppressors p53 or ARF.Oncogene. 27(12):1705-15.
Mackinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes SJ, Sethi T.  2008.  Regulation of alternative macrophage activation by galectin-3.J Immunol. 180(4):2650-8.
2006
Foukas LC, Claret M, Pearce W, Okkenhaug K, Meek S, Peskett E, Sancho S, Smith AG, Withers DJ, Vanhaesebroeck B.  2006.  Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation.Nature. 441(7091):366-70.
2004
Krawczyk M, Peyraud N, Rybtsova N, Masternak K, Bucher P, le Barras E, Reith W.  2004.  Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.J Immunol. 173(10):6200-10.
Chambers I, Smith A.  2004.  Self-renewal of teratocarcinoma and embryonic stem cells.Oncogene. 23(43):7150-60.